|
Feb 25
|
Exploring Three High Growth Tech Stocks In The United States
|
|
Feb 24
|
2 Stocks Down 59% and 34% to Buy and Hold
|
|
Feb 24
|
Exact Sciences to Participate in March Investor Conferences
|
|
Feb 21
|
Exact Sciences Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 20
|
Why Exact Sciences (EXAS) Shares Are Trading Lower Today
|
|
Feb 20
|
Q4 2024 Exact Sciences Corp Earnings Call
|
|
Feb 20
|
EXAS Q4 Loss Narrower Than Expected, Stock Falls, Revenues Up Y/Y
|
|
Feb 20
|
Exact Sciences Corp (EXAS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Feb 20
|
Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript
|
|
Feb 19
|
Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 19
|
Exact Sciences: Q4 Earnings Snapshot
|
|
Feb 19
|
Exact Sciences’s (NASDAQ:EXAS) Q4: Beats On Revenue
|
|
Feb 19
|
Exact Sciences Announces Fourth Quarter 2024 Results
|
|
Feb 18
|
Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect
|
|
Feb 13
|
Guardant Health (GH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Feb 12
|
Trickle-down effect of NIH funding battle worries healthcare analysts and medical experts
|
|
Feb 12
|
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Feb 10
|
When Can We Expect A Profit From Exact Sciences Corporation (NASDAQ:EXAS)?
|
|
Jan 3
|
Exact Sciences price target raised to $70 from $60 at Evercore ISI
|
|
Jan 2
|
Exact Sciences to Participate in J.P. Morgan Healthcare Conference
|